Blenrep 70mg/100mg powder for concentrate for solution for infusion
*Company:
GlaxoSmithKline (Ireland) LtdStatus:
NewLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 11 December 2025
File name
ie-spc-combined-blenrep-issue1draft1-meds.ie.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
New SPC for medicines.ie
Updated on 11 December 2025
File name
ie-pl-combined-blenrep-issue2draft1-meds.ie.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New PIL for medicines.ie
GlaxoSmithKline (Ireland) Ltd
Address:
12 Riverwalk, Citywest Business Campus, Dublin 24, IrelandTelephone:
+353 1 495 5000Medical Information Direct Line:
1 800 244 255